29.53
Heartflow Inc stock is traded at $29.53, with a volume of 1.61M.
It is down -3.34% in the last 24 hours and up +19.60% over the past month.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
See More
Previous Close:
$30.55
Open:
$30.39
24h Volume:
1.61M
Relative Volume:
1.03
Market Cap:
$2.53B
Revenue:
$176.04M
Net Income/Loss:
$-116.79M
P/E Ratio:
-21.03
EPS:
-1.4041
Net Cash Flow:
$-59.05M
1W Performance:
-10.32%
1M Performance:
+19.60%
6M Performance:
-21.30%
1Y Performance:
+0.00%
Heartflow Inc Stock (HTFL) Company Profile
Name
Heartflow Inc
Sector
Industry
Phone
650-241-1221
Address
331 E EVELYN AVENUE, MOUNTAIN VIEW
Compare HTFL vs VEEV, BTSG, TEM, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HTFL
Heartflow Inc
|
29.53 | 2.62B | 176.04M | -116.79M | -59.05M | -1.4041 |
|
VEEV
Veeva Systems Inc
|
158.22 | 25.89B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
48.15 | 9.17B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
TEM
Tempus Ai Inc
|
50.02 | 9.17B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
HQY
Healthequity Inc
|
81.48 | 6.86B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
25.27 | 4.84B | 1.10B | 112.09M | 283.19M | 0.6096 |
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-26 | Initiated | Wells Fargo | Overweight |
| Sep-02-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | JP Morgan | Overweight |
| Sep-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-02-25 | Initiated | Piper Sandler | Overweight |
| Sep-02-25 | Initiated | Stifel | Buy |
View All
Heartflow Inc Stock (HTFL) Latest News
Heartflow (NASDAQ: HTFL) details 2026 virtual meeting, board elections and pay - Stock Titan
Why HeartFlow Stock Is Racing Higher Today - TipRanks
HeartFlow files patent infringement lawsuit against Cleerly - MSN
A Look At HeartFlow (HTFL) Valuation As Investors Weigh Growth Hopes Against High P/S Multiple - Yahoo Finance
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026 - The Manila Times
Heartflow schedules first-quarter earnings call after May 14 close - Stock Titan
HTFL (Heartflow Inc.) Q4 2025 adjusted EPS handily beats forecasts, stock registers modest intraday gain.Hold Rating - Xã Thanh Hà
HTFL (Heartflow) Q4 2025 30 percent positive EPS surprise lifts shares almost 1 percent in today’s trading.Verified Analyst Reports - Xã Thanh Hà
Heartflow Accuses Rival of Building Competing AI Heart Tech on Stolen Secrets - Law.com
Lobbying Update: $60,000 of HEARTFLOW INC. lobbying was just disclosed - Quiver Quantitative
Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft - Above the Law
HTFL News | HEARTFLOW INC (NASDAQ:HTFL) - ChartMill
Heartflow (HTFL) Stock: Suitable for Investors? (Gathers Momentum) 2026-04-18Community Risk Signals - Xã Thanh Hà
HeartFlow (HTFL) Sees Consistent 'Buy' Rating from Canaccord Gen - GuruFocus
We're Interested To See How HeartFlow (NASDAQ:HTFL) Uses Its Cash Hoard To Grow - Moomoo
Heartflow, Inc. (NASDAQ:HTFL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
HeartFlow2026 Funding Rounds & List of Investors - Tracxn
Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 22,562 Shares - MarketBeat
Heartflow CEO Farquhar sells $602,856 in shares By Investing.com - Investing.com South Africa
Heartflow CEO Farquhar sells $602,856 in shares - Investing.com
Heartflow (HTFL) CEO logs small Rule 10b5-1 stock sale - Stock Titan
Heartflow Sues Cleerly Over AI Cardiology Technology - Medical Product Outsourcing
Why HeartFlow Stock Is Surging After Legal Action - TipRanks
CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $43 - Moomoo
Heartflow sues Cleerly over patent infringement allegations - Yahoo Finance
Heartflow Insider Sold Shares Worth $602,857, According to a Recent SEC Filing - marketscreener.com
AI Cardiac Imaging Co. Hits Ex-Consultant With IP Suit - Law360
Heartflow sues rival Cleerly over AI cardiology technology - Reuters
Heartflow stock rating reiterated at Buy by Canaccord on IP suit - Investing.com South Africa
Heartflow stock rating reaffirmed at Buy by Stifel amid patent suit - Investing.com UK
Heartflow stock rating reaffirmed at Buy by Stifel amid patent suit By Investing.com - Investing.com India
Heartflow Says Cardiac Imaging Rival Infringed AI Tech Patents - Bloomberg Law News
HeartFlow files patent suit against Cleerly over CAD tech By Investing.com - Investing.com South Africa
HeartFlow files patent suit against Cleerly over CAD tech - Investing.com
Heartflow Files Patent Infringement Lawsuit Against Cleerly - The Manila Times
HTFL: Heartflow, Inc.Comparison to Industry - Zacks Investment Research
HTFL Options Volatility — NASDAQ:HTFL - TradingView — Track All Markets
HTFL Options Chain — NASDAQ:HTFL - TradingView
HTFL (NASDAQ) Form 144: Affiliate/insider lists 22,562-share resale and prior sales - Stock Titan
HeartFlow Stock Surges on Bullish Outlook and Target - TipRanks
Stifel reiterates Heartflow stock rating on clinical data strength By Investing.com - Investing.com South Africa
Heartflow Inc Stock (HTFL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):